C. Mavroudis et al., 46 YEARS OF PATENT DUCTUS-ARTERIOSUS DIVISION AT CHILDRENS-MEMORIAL-HOSPITAL-OF-CHICAGO - STANDARDS FOR COMPARISON, Annals of surgery, 220(3), 1994, pp. 402-410
Objective The authors reviewed a large surgical experience (during liv
e decades) with ligation and division of patent ductus arteriosus (PDA
) in light of previously reported historical standards and present-day
alternatives. Summary Background Data Ligation of PDA was first perfo
rmed by Gross in 1938. Various surgical techniques used since then hav
e included ligation and division, simple ligation, and hemaclip applic
ation. Recently introduced therapies include percutaneous transcathete
r ductal closure devices (PTDC) and video-assisted thoracotomy (VAT).
Percutaneous transcatheter ductal closure device protagonists cite sur
gical recurrence rates as high as 22% to justify continued application
. Methods Between 1947 and 1993, 98.2% of 1108 patients (premature bab
ies excluded) had interruption of PDA by ligation and division. Recent
improvements have included muscle-sparing thoracotomy, minimal use of
tube thoracostomy, and same-day surgery. Results Mortality was zero a
nd morbidity (4.4%) has been low over time. Mean age at surgery has de
creased from 5.9 +/- 3.3 years to 3.6 +/- 3.8 years (p < 0.001); patie
nts requiring blood transfusion decreased from 34% to 4.6% (p < 0.001)
; and length of hospital stay (LOS) has decreased from 12.1 +/- 2.9 da
ys to 3.8 +/- 2.1 days (p < 0.001). Length of stay for the last 27 pat
ients was 2.8 +/- 8 days. Patent ductus arteriosus recurrence rate is
zero with this technique. Conclusions Recurrence rates for PTDC are hi
gh with as yet unknown consequences of large catheter vascular access,
endocarditis, or left pulmonary artery stenosis. Video-assisted thora
cotomy for PDA interruption has the potential for uncontrolled exsangu
inating hemorrhage. Open thoracotomy for PDA ligation and division can
be performed safely and without recurrence through a muscle-sparing i
ncision with short LOS. All other therapeutic interventions must be co
mpared to these standards.